FindTrial
Sign In

Routine pathogen detection combined with metagenomic next-generation sequencing technology in hospitalized elderly patients with community-acquired pneumonia——A prospective real-world study

Routine pathogen detection combined with metagenomic next-generation sequencing technology in hospitalized elderly patients with community-acquired pneumonia——A prospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063649
Enrollment
Unknown
Registered
2022-09-13
Start date
2022-09-12
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-acquired pneumonia

Interventions

Case series:None

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: =65 years old; Meet the diagnostic criteria of CAP; Agree to take samples for mNGS technical pathogen detection; Sign the informed consent form.

Exclusion criteria

Exclusion criteria: With other diseases at the end stage, the expected survival time is less than 3 months; Included in other studies and conflict with this study.

Design outcomes

Primary

MeasureTime frame
Positive rate of pathogens;—

Secondary

MeasureTime frame
adjustment rate of antibiotic;length of hospitalization;—

Countries

China

Contacts

Public ContactJinxiang Wang

Beijing Luhe Hospital, Capital Medical University

wangjx0090@sina.com+86 13911469017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026